Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
AssigneeBayer Intellectual Property GmbH
InventorsStefan Golz, Martina Delbeck, Heinrich Meier, Andreas Geerts, Thomas Mondritzki, Hubert Trübel
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of cathepsin K and/or cathepsin S inhibitors in a method for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure.
Claims8
A method of treatment and/or prophylaxis of pulmonary hypertension and/or acute or chronic heart failure comprising administering an effective amount of a Cathepsin K inhibitor to a human or animal in need thereof.
A method of treatment and/or prophylaxis of pulmonary hypertension comprising administering to a human or animal in need thereof an effective amount of a compound of formula (I)
- or a salt thereof.
A method for the treatment and/or prophylaxis of pulmonary hypertension and/or acute or chronic heart failure in humans and animals comprising administering to a human or animal a therpeutically effective amount of a pharmaceutical composition comprising at least one Cathepsin K inhibitor and an inert, non-toxic, pharmaceutically acceptable additive.
Dependencies are inferred from the claim text.